Selective agonist of toll-like receptor 3

Details for Australian Patent Application No. 2009215128 (hide)

Owner Hemispherx Biopharma, Inc.

Inventors Carter, William A.; Strayer, David

Agent Cullens

Pub. Number AU-A-2009215128

PCT Pub. Number WO2009/102496

Priority 61/029,307 15.02.08 US; 61/051,606 08.05.08 US

Filing date 17 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102496 Priority application(s): WO2009/102496

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215129-Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species

2009215118-A humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration